Results 151 to 160 of about 304,235 (279)

Predicting Epileptogenic Tubers in Patients With Tuberous Sclerosis Complex Using a Fusion Model Integrating Lesion Network Mapping and Machine Learning

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Accurate localization of epileptogenic tubers (ETs) in patients with tuberous sclerosis complex (TSC) is essential but challenging, as these tubers lack distinct pathological or genetic markers to differentiate them from other cortical tubers.
Tinghong Liu, Qi Wang, Suhui Kuang, Dezhi Cao, Ping Ding, Shaohui Zhang, Haihua Wei, Zhirong Wei, Jinshan Xu, Xinyu Huang, Bing Liu, Shuli Liang   +11 more
wiley   +1 more source

Non-motor symptoms as critical predictors of quality of life in Parkinson's disease: a machine learning approach. [PDF]

Health Qual Life Outcomes
Magano D, Barros AS, Massano J, Alsuwaidi L, Taveira-Gomes T.   +4 more
europepmc   +1 more source

The Non-Motor Prodromal Symptoms of Parkinson's Disease: A Review [PDF]

Amjad Mhanna, Subhia Maya, Ali Ghassa, Abdallah Aladna, Zuheir Alshehabi   +4 more
openalex   +1 more source

Life‐Threatening Bradycardia in Anti‐NMDA‐Receptor Encephalitis and a Novel Use for Permanent Pacing

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Pediatric anti‐NMDA receptor encephalitis (pNMDARE) is an autoantibody‐mediated disorder that can cause severe autonomic dysfunction, including symptomatic bradycardia and asystole. Dysautonomia can last for years, making it very challenging to manage.
Sarah Tucker, Abhijit Das, Andres Jimenez, Areeba Basit, Yike Jiang, Emily A. Smitherman, Heather Van Mater, Taylor Howard, Alexander J. Sandweiss, Kristen S. Fisher   +9 more
wiley   +1 more source

Redefining Non-Motor Symptoms in Parkinson's Disease. [PDF]

J Pers Med
Peña-Zelayeta L, Delgado-Minjares KM, Villegas-Rojas MM, León-Arcia K, Santiago-Balmaseda A, Andrade-Guerrero J, Pérez-Segura I, Ortega-Robles E, Soto-Rojas LO, Arias-Carrión O.   +9 more
europepmc   +1 more source

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin, Liu Dong, Ying Wang, Dingxian He, Chong Yan, Jianying Xi, Haoqin Jiang, Yu Shi, Ming Guan, Chongbo Zhao, Jie Song, Sushan Luo   +11 more
wiley   +1 more source

Disability and Non-Motor Symptoms in Multiple Sclerosis: Exploring Associations and Predictive Factors. [PDF]

Brain Sci
Jerković A, Safić IS, Pavelin S, Pleić N, Duka Glavor K, Vujović I, Šoda J, Duranović J, Rogić Vidaković M.   +8 more
europepmc   +1 more source

Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease [PDF]

, 2016
Ilaria Cova, Maria Elena Di Battista, Nicola Vanacore, Chiara Papi, G. Alampi, Alfonso Rubino, Mariarosaria Valente, G. Meco, P. Contri, Alessandra Di Pucchio, Eleonora Lacorte, Alberto Priori, C. Mariani, Simone Pomati   +13 more
openalex   +1 more source

Developmental, Neuroanatomical and Cellular Expression of Genes Causing Dystonia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Dystonia is one of the most common movement disorders, with variants in multiple genes identified as causative. However, an understanding of which developmental stages, brain regions, and cell types are most relevant is crucial for developing relevant disease models and therapeutics.
Darren Cameron, Nicholas E. Clifton, Daniel Cabezas de la Fuente, Peter Holmans, Nicholas J. Bray, Kathryn J. Peall   +5 more
wiley   +1 more source

Beyond the Surface: Investigating the Potential Mechanisms of Non-Motor Symptoms in Myasthenia Gravis. [PDF]

Eur J Neurol
Wang B, Liu D, Yang Y, Zhu R.
europepmc   +1 more source